Neonatal Cardiac Macrophages
Neonatal Cardiac Macrophages - Related Videos
08:16
Neonatal Cardiac Scaffolds: Novel Matrices for Regenerative Studies
0 Views •
Cited by 3 •
2016
In these studies, we provide methodology for novel, neonatal, murine cardiac scaffolds for use in regenerative studies.
06:10
Transplantation of Neonatal Mouse Cardiac Macrophages into Adult Mice
0 Views •
Cited by 2 •
2021
We provide a protocol for neonatal cardiac macrophage separation and transplantation into an adult mouse heart, which could be a promising way to promote cardiac repair.
07:48
Myocardial Infarction in Neonatal Mice, A Model of Cardiac Regeneration
0 Views •
Cited by 37 •
2016
This protocol describes a highly reproducible model of cardiac regeneration by surgical induction of myocardial infarction in the left ventricle of postnatal day 1 mice. The method involves induction of hypothermic anesthesia and ligation of the left anterior descending coronary artery.
03:58
Apical Resection Neonatal Mouse Model: A Surgical Procedure to Amputate the Ventricular Apex to Study Regenerative Potential in a Neonate Mouse Heart
0 Views •
2025
In this video, we demonstrate the procedure to surgically remove the left ventricular apex of a neonatal mouse heart.
07:50
Isolation and Culture of Neonatal Mouse Cardiomyocytes
0 Views •
Cited by 187 •
2013
Primary mouse cardiomyocyte cultures are one of the pivotal tools for the investigation of myofibrillar organization and function. The following protocol describes the isolation and culture of primary cardiomyocytes from neonatal mouse hearts. The resulting cardiomyocyte cultures may be subsequently used for a variety of biomechanical, biochemical and cell-biological assays.
FAQs
Local damage and biochemical signals direct these macrophages toward responses suited to the newborn heart’s immediate needs. They can remove pathogens, cellular debris, and dying cells through phagocytosis and efferocytosis, while also releasing cytokines and growth-associated factors. This combination links clearance of harmful material with signals that affect cardiac repair, development, and tissue homeostasis.
Phagocytosis allows macrophages to remove pathogens and debris, whereas efferocytosis specifically addresses dying cells. Together, these activities help control material that could disrupt the cardiac environment and provide a biochemical connection between immune cleanup and tissue maintenance. Their importance extends beyond removal because macrophage activity also influences neighboring cardiomyocytes, fibroblasts, and vascular cells.
Communication occurs partly through cytokines and growth-associated factors released by the macrophages. These signals can influence cardiomyocytes, which generate contractile tissue, fibroblasts, which contribute to the cardiac structural environment, and vascular cells. Consequently, macrophage activity can connect innate immune responses with coordinated changes in cardiac development, repair, and homeostasis rather than acting as an isolated defense process.
The neonatal heart can regenerate more effectively than the adult heart, making its macrophage responses especially relevant to cardiac biology. Studying these cells may reveal how immune activity is coordinated with repair in early life and why comparable recovery is less effective in adulthood. This comparison focuses attention on molecular pathways that could support myocardial repair after injury.
A useful investigation can follow how macrophages respond to local damage, process pathogens and dying cells, and release factors that affect neighboring cardiac and vascular populations. Researchers can then relate these activities to development, repair, and homeostasis. Examining the full sequence, rather than a single immune function, helps connect cellular behavior with the regenerative properties of the neonatal heart.
Research on these cells may identify molecular pathways that reduce excessive inflammation while supporting myocardial repair. Their interactions with cardiomyocytes, fibroblasts, and vascular cells also provide potential guidance for designing regenerative therapies for cardiac injury. The therapeutic goal is not simply to increase immune activity, but to understand which macrophage-associated signals favor effective tissue recovery and maintenance.